{"entity":{"type":"insider","cik":"0001837798","url":"/insider/0001837798","json_url":"/insider/0001837798.json","name":"Robertson Stephen P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2021-01-29","last":"2025-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Robertson Stephen P.","source":"filing","n_filings":5,"first_seen":"2021-01-29","last_seen":"2025-03-04"}],"transactions":[{"id":4771775,"accession":"0001600620-25-000019","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001600620-25-000019","line_url":"/filing/0001600620-25-000019#line-4","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837798","owner_name":"Robertson Stephen P.","owner_url":"/insider/0001837798","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57607.0,"shares_display":"57,607","price_per_share":7.92,"price_display":"7.92","price_state":"stated","total_value":456247.44,"total_display":"456,247.44","shares_owned_after":509276.0,"shares_owned_after_display":"509,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-04","scope":"insider"},{"id":4771770,"accession":"0001600620-25-000019","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001600620-25-000019","line_url":"/filing/0001600620-25-000019#line-3","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837798","owner_name":"Robertson Stephen P.","owner_url":"/insider/0001837798","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64872.0,"shares_display":"64,872","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":518976.0,"total_display":"518,976.00","shares_owned_after":566883.0,"shares_owned_after_display":"566,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":2224652,"accession":"0001600620-24-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000034","line_url":"/filing/0001600620-24-000034#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837798","owner_name":"Robertson Stephen P.","owner_url":"/insider/0001837798","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57745.0,"shares_display":"57,745","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":323372.0,"total_display":"323,372.00","shares_owned_after":443824.0,"shares_owned_after_display":"443,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-07","scope":"insider"},{"id":9292956,"accession":"0001600620-24-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000015","line_url":"/filing/0001600620-24-000015#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837798","owner_name":"Robertson Stephen P.","owner_url":"/insider/0001837798","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19644.0,"shares_display":"19,644","price_per_share":8.78,"price_display":"8.78","price_state":"stated","total_value":172474.32,"total_display":"172,474.32","shares_owned_after":303122.0,"shares_owned_after_display":"303,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2024-02-22","scope":"insider"},{"id":8211730,"accession":"0001628280-23-006530","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-006530","line_url":"/filing/0001628280-23-006530#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837798","owner_name":"Robertson Stephen P.","owner_url":"/insider/0001837798","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19402.0,"shares_display":"19,402","price_per_share":8.94,"price_display":"8.94","price_state":"stated","total_value":173453.88,"total_display":"173,453.88","shares_owned_after":303364.0,"shares_owned_after_display":"303,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":4392051,"accession":"0001628280-21-001096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-001096","line_url":"/filing/0001628280-21-001096#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837798","owner_name":"Robertson Stephen P.","owner_url":"/insider/0001837798","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":16.14,"price_display":"16.14","price_state":"stated","total_value":14526.0,"total_display":"14,526.00","shares_owned_after":2720.0,"shares_owned_after_display":"2,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-28","filed_date":"2021-01-29","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Officer (EVP, General Counsel)","n_filings":5,"first_seen":"2021-01-29","last_seen":"2025-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001837798","retrieved_at":"2026-08-20T16:33:11+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}